Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
26.66
-0.06 (-0.22%)
At close: Mar 6, 2026, 4:00 PM EST
26.06
-0.60 (-2.26%)
After-hours: Mar 6, 2026, 6:38 PM EST
Immunovant Market Cap
Immunovant has a market cap or net worth of $5.43 billion as of March 6, 2026. Its market cap has increased by 56.21% in one year.
Market Cap
5.43B
Enterprise Value
4.43B
1-Year Change
56.21%
Ranking
Category
Stock Price
$26.66
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $5.43B, an increase of 4,262.75%. That is a compound annual growth rate of 75.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cogent Biosciences | 5.97B |
| Protagonist Therapeutics | 5.88B |
| CRISPR Therapeutics AG | 5.42B |
| Celcuity | 5.32B |
| Caris Life Sciences | 5.25B |
| CG Oncology | 5.22B |
| Mirum Pharmaceuticals | 5.21B |
| Scholar Rock Holding | 5.20B |